MolNFT v1 · #185776 · protein
Crystal structure of a mutant (P393GX) thyroid receptor alpha ligand binding domain designed to model dominant negative human mutations.
7QDT: “Crystal structure of a mutant (P393GX) thyroid receptor alpha ligand binding domain designed to model…”. X-ray diffraction, 1 ligand (T3). MolNFT v1 #185776 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7QDT
- Type
- protein
- Length
- 236 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P10827
- Ligands
- T3
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 236 | — | P10827 |
Ligands and binding sites
- T3 · 3,5,3'triiodothyronine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7QDT · Crystal structure of a mutant (P393GX) Thyroid Receptor Alpha ligand binding domain… · the same entry in another collection · chain A against A, TM-score 1.00
- P10827 · AlphaFold monomer V2.0 prediction for thyroid hormone receptor alpha (P10827) · a predicted model of the same protein · chain A against A, TM-score 0.96
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P10827
- Elsewhere: RCSB PDB 7QDT · PDBe 7QDT · UniProt P10827
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.